Jeevan Scientific Technology Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 17.40 | 12 | 4.76 | -- |
Op profit growth | (286) | 11.40 | 73.80 | -- |
EBIT growth | (450) | (8.30) | 62 | -- |
Net profit growth | (7,781) | (88) | (13,597) | -- |
Profitability ratios (%) | ||||
OPM | (27) | 16.80 | 16.80 | 10.20 |
EBIT margin | (32) | 10.90 | 13.30 | 8.58 |
Net profit margin | (36) | 0.55 | 4.96 | -- |
RoCE | (19) | 6.67 | 11.90 | -- |
RoNW | (9.50) | 0.14 | 2.19 | -- |
RoA | (5.20) | 0.08 | 1.11 | -- |
Per share ratios () | ||||
EPS | -- | 0.10 | 0.97 | -- |
Dividend per share | -- | -- | -- | -- |
Cash EPS | (8.20) | (1.80) | (0.30) | (1.10) |
Book value per share | 15.20 | 19.20 | 18.20 | 6.24 |
Valuation ratios | ||||
P/E | -- | 417 | 41.50 | -- |
P/CEPS | (2) | (24) | (116) | (34) |
P/B | 1.06 | 2.17 | 2.22 | 6.22 |
EV/EBIDTA | (11) | 15 | 12.50 | 15.80 |
Payout (%) | ||||
Dividend payout | -- | -- | -- | -- |
Tax payout | (19) | (69) | (11) | (103) |
Liquidity ratios | ||||
Debtor days | 176 | 247 | 186 | -- |
Inventory days | 8 | 5.10 | 27.60 | -- |
Creditor days | (55) | (79) | (74) | -- |
Leverage ratios | ||||
Interest coverage | 2.78 | (1.20) | (1.70) | (1.20) |
Net debt / equity | 0.68 | 0.79 | 0.49 | 2.88 |
Net debt / op. profit | (2.50) | 5.08 | 2.67 | 6.16 |
Cost breakup () | ||||
Material costs | (3.60) | (6.40) | (0.90) | (0.90) |
Employee costs | (44) | (28) | (12) | (20) |
Other costs | (79) | (49) | (70) | (69) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 23.90 | 20.40 | 18.20 | 17.40 |
yoy growth (%) | 17.40 | 12 | 4.76 | -- |
Raw materials | (0.90) | (1.30) | (0.20) | (0.20) |
As % of sales | 3.61 | 6.37 | 0.87 | 0.87 |
Employee costs | (10) | (5.70) | (2.30) | (3.60) |
As % of sales | 43.60 | 27.80 | 12.40 | 20.40 |
Other costs | (19) | (10) | (13) | (12) |
As % of sales | 79.40 | 49 | 69.90 | 68.50 |
Operating profit | (6.40) | 3.42 | 3.07 | 1.77 |
OPM | (27) | 16.80 | 16.80 | 10.20 |
Depreciation | (3.90) | (2.10) | (1.20) | (0.70) |
Interest expense | (2.80) | (1.90) | (1.40) | (1.30) |
Other income | 2.53 | 0.92 | 0.58 | 0.40 |
Profit before tax | (11) | 0.36 | 1.01 | 0.22 |
Taxes | 1.96 | (0.30) | (0.10) | (0.20) |
Tax rate | (19) | (69) | (11) | (103) |
Minorities and other | -- | -- | -- | -- |
Adj. profit | (8.60) | 0.11 | 0.90 | -- |
Exceptional items | -- | -- | -- | -- |
Net profit | (8.60) | 0.11 | 0.90 | -- |
yoy growth (%) | (7,781) | (88) | (13,597) | -- |
NPM | (36) | 0.55 | 4.96 | -- |
- Switch to
-
Tabular DataGraph
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | (11) | 0.36 | 1.01 | 0.22 |
Depreciation | (3.90) | (2.10) | (1.20) | (0.70) |
Tax paid | 1.96 | (0.30) | (0.10) | (0.20) |
Working capital | 0.18 | 3.86 | (3.90) | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | (12) | 1.85 | (4.20) | -- |
Capital expenditure | 31.90 | 14.30 | (14) | -- |
Free cash flow | 19.60 | 16.20 | (19) | -- |
Equity raised | 23.50 | 20.20 | 15.10 | -- |
Investments | -- | -- | -- | -- |
Debt financing/disposal | 11.80 | 10.30 | 3.75 | -- |
Dividends paid | -- | -- | -- | -- |
Other items | -- | -- | -- | -- |
Net in cash | 54.90 | 46.70 | 0.29 | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Equity capital | 15.30 | 15.30 | 14.60 | 14 |
Preference capital | -- | -- | -- | -- |
Reserves | 7.92 | 16.50 | 7.42 | 2.84 |
Net worth | 23.20 | 31.80 | 22 | 16.90 |
Minority interest | ||||
Debt | 18 | 18.20 | 18.80 | 8.45 |
Deferred tax liabilities (net) | 0.40 | 0.40 | 0.26 | 0.11 |
Total liabilities | 41.60 | 50.40 | 41.10 | 25.40 |
Fixed assets | 30.50 | 32.60 | 28.20 | 16.40 |
Intangible assets | ||||
Investments | -- | -- | -- | -- |
Deferred tax asset (net) | 1.96 | -- | 0.12 | 0.22 |
Net working capital | 6.86 | 14.10 | 11.30 | 8.62 |
Inventories | 0.95 | 0.23 | 0.10 | 0.47 |
Inventory Days | 14.50 | -- | 1.79 | 9.42 |
Sundry debtors | 6.84 | 14.70 | 16.30 | 11.30 |
Debtor days | 104 | -- | 292 | 227 |
Other current assets | 11.80 | 10.10 | 3.38 | 2.38 |
Sundry creditors | (4.50) | (4.40) | (4.60) | (2.70) |
Creditor days | 69.20 | -- | 82.50 | 54.10 |
Other current liabilities | (8.20) | (6.50) | (3.80) | (2.90) |
Cash | 2.20 | 3.67 | 1.42 | 0.26 |
Total assets | 41.60 | 50.40 | 41.10 | 25.50 |
- Switch to
-
ConsolidatedStandalone
Particulars ( Rupees In Crores.) | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 |
---|---|---|---|---|---|
Gross Sales | 32.50 | 16.90 | 21.80 | 16.10 | 12.90 |
Excise Duty | -- | -- | -- | -- | -- |
Net Sales | 32.50 | 16.90 | 21.80 | 16.10 | 12.90 |
Other Operating Income | -- | -- | -- | -- | -- |
Other Income | 1.38 | 0.92 | 0.90 | 0.65 | 0.30 |
Total Income | 33.90 | 17.80 | 22.70 | 16.70 | 13.20 |
Total Expenditure ** | 19.10 | 16.50 | 15.70 | 13.40 | 10.80 |
PBIDT | 14.70 | 1.25 | 6.97 | 3.32 | 2.40 |
Interest | 1.94 | 2.04 | 1.55 | 1.51 | 1.01 |
PBDT | 12.80 | (0.80) | 5.42 | 1.81 | 1.39 |
Depreciation | 2.98 | 2.99 | 2.43 | 1.51 | 0.86 |
Minority Interest Before NP | -- | -- | -- | -- | -- |
Tax | 1.92 | (0.70) | 0.39 | 0.07 | 0.12 |
Deferred Tax | -- | -- | -- | -- | -- |
Reported Profit After Tax | 7.90 | (3.10) | 2.61 | 0.22 | 0.41 |
Minority Interest After NP | -- | -- | -- | -- | -- |
Net Profit after Minority Interest | 7.90 | (3.10) | 2.61 | 0.22 | 0.41 |
Extra-ordinary Items | -- | -- | -- | -- | (0.10) |
Adjusted Profit After Extra-ordinary item | 7.90 | (3.10) | 2.61 | 0.22 | 0.50 |
EPS (Unit Curr.) | 5.16 | (2.10) | 1.71 | 0.24 | 0.51 |
Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
Dividend (%) | -- | -- | -- | -- | -- |
Equity | 15.30 | 15.30 | 15.30 | 9.28 | 8.11 |
Public Shareholding (Number) | -- | -- | -- | -- | -- |
Public Shareholding (%) | -- | -- | -- | -- | -- |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
PBIDTM(%) | 45.40 | 7.41 | 32 | 20.60 | 18.60 |
PBDTM(%) | 39.40 | (4.70) | 24.90 | 11.20 | 10.80 |
PATM(%) | 24.30 | (18) | 12 | 1.37 | 3.17 |